Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages.

AIM Paracrine interaction between macrophages and adipocytes in obese visceral fat tissues is thought to be a trigger of chronic inflammation. The immunomodulatory effect of the short chain fatty acid, butyric acid, has been demonstrated. We hypothesize that sodium butyrate (butyrate) attenuates inflammatory responses and lipolysis generated by the interaction of macrophages and adipocytes. METHODS Using contact or transwell co-culture methods with differentiated 3T3-L1 adipocytes and RAW264.7 macrophages, we investigated the effects of butyrate on the production of tumor necrosis factor alpha (TNF-α), monocyte chemoattractant protein 1 (MCP-1), interleukin 6 (IL-6), and the release of free glycerol, free fatty acids (FFAs) into the medium. We also examined the activity of nuclear factor-kappaB (NF-κB) and the phosphorylation of mitogen-activated protein kinases (MAPKs) in co-cultured macrophages, as well as lipase activity and expression in co-cultured adipocytes. RESULTS We found increased production of TNF-α, MCP-1, IL-6, and free glycerol, FFAs in the co-culture medium, and butyrate significantly reduced them. Butyrate inhibited the phosphorylation of MAPKs, the activity of NF-κB in co-cultured macrophages, and suppressed lipase activity in co-cultured adipocytes. Lipase inhibitors significantly attenuated the production of TNF-α, MCP-1 and IL-6 in the co-culture medium as effectively as butyrate. Butyrate suppressed the protein production of adipose triglyceride lipase, hormone sensitive lipase, and fatty acid-binding protein 4 in co-cultured adipocytes. Pertussis toxin, which is known to block GPR41 completely, inhibited the antilipolysis effect of butyrate. CONCLUSION Butyrate suppresses inflammatory responses generated by the interaction of adipocytes and macrophages through reduced lipolysis and inhibition of inflammatory signaling.

[1]  R. Curi,et al.  Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice. , 2012, American journal of physiology. Endocrinology and metabolism.

[2]  M. Furuhashi,et al.  Lipid Chaperones and Metabolic Inflammation , 2011, International journal of inflammation.

[3]  M. Usami,et al.  Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells , 2011, Journal of clinical biochemistry and nutrition.

[4]  M. Usami,et al.  The effect of irradiation wavelengths and the crystal structures of titanium dioxide on the formation of singlet oxygen for bacterial killing , 2011 .

[5]  O. Ohara,et al.  Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue , 2011, Proceedings of the National Academy of Sciences.

[6]  M. Usami,et al.  Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats. , 2011, Clinical nutrition.

[7]  Mark Woodward,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. , 2011, Lancet.

[8]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.

[9]  P. de Vos,et al.  Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? , 2010, Current opinion in clinical nutrition and metabolic care.

[10]  M. Comalada,et al.  Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. , 2010, Immunobiology.

[11]  T. Suganami,et al.  Adipose tissue macrophages: their role in adipose tissue remodeling , 2010, Journal of leukocyte biology.

[12]  A. Chait,et al.  Saturated fatty acids and inflammation: who pays the toll? , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[13]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[14]  R. Tulley,et al.  Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. , 2008, American journal of physiology. Endocrinology and metabolism.

[15]  V. Hombach,et al.  T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Usami,et al.  Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. , 2008, Nutrition research.

[17]  J. Granneman,et al.  Location, location: protein trafficking and lipolysis in adipocytes , 2008, Trends in Endocrinology & Metabolism.

[18]  W. Cawthorn,et al.  TNF‐α and adipocyte biology , 2008 .

[19]  E. Thompson,et al.  Monocyte Chemoattractant Protein‐1 and Nitric Oxide Promote Adipogenesis in a Model That Mimics Obesity , 2007, Obesity.

[20]  R. Curi,et al.  Mechanisms by which fatty acids regulate leucocyte function. , 2007, Clinical science.

[21]  M. Kaneki,et al.  Nitrosative stress and pathogenesis of insulin resistance. , 2006, Antioxidants & redox signaling.

[22]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[23]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[24]  P. Reaven,et al.  Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. , 2006, Biochemical and biophysical research communications.

[25]  Ki-Choon Choi,et al.  Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. , 2005, Endocrinology.

[26]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[27]  R. Kedzierski,et al.  Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[29]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[30]  D. Bernlohr,et al.  Fatty Acid-binding Protein-Hormone-sensitive Lipase Interaction , 2003, Journal of Biological Chemistry.

[31]  M. Parmentier,et al.  Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation* , 2003, Journal of Biological Chemistry.

[32]  S. Dowell,et al.  The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* , 2003, The Journal of Biological Chemistry.

[33]  A. Andoh,et al.  Role of dietary fiber and short-chain fatty acids in the colon. , 2003, Current pharmaceutical design.

[34]  M. Lazar,et al.  A futile metabolic cycle activated in adipocytes by antidiabetic agents , 2002, Nature Medicine.

[35]  L. Bukowiecki,et al.  Mechanisms of leptin secretion from white adipocytes. , 2002, American journal of physiology. Cell physiology.

[36]  P. Clifton,et al.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. , 2001, Physiological reviews.

[37]  R. Macdermott,et al.  Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Lawrence A Leiter,et al.  Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. , 1997, Metabolism: clinical and experimental.

[39]  P. Gibson,et al.  Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. , 1995, Gut.

[40]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[41]  Duncombe Wg.  The colorimetric micro-determination of long-chain fatty acids. , 1963 .

[42]  W. Cawthorn,et al.  TNF-alpha and adipocyte biology. , 2008, FEBS letters.

[43]  Hee-Sun Kim,et al.  Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells : Involvement of NF-κB and ERK signaling pathways , 2007 .

[44]  楯谷 三四郎.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity , 2006 .

[45]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[46]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.

[47]  K. Boockvar,et al.  Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. , 1996, Methods in enzymology.

[48]  W. G. Duncombe,et al.  The colorimetric micro-determination of long-chain fatty acids. , 1963, The Biochemical journal.